01.20.22
Walgreens Boots Alliance CEO Rosalind Brewer said the group is “exploring strategic options” for the Boots business, which operates a chain of drugstores in the UK. The move reflects Walgreens' plan to increase its US healthcare business. Brewer's comments came during a presentation at the JPMorgan Annual Healthcare Conference.
“We have initiated a strategic review of the Boots business,” Brewer said. “This review is very much in line with our renewed priorities and strategic direction, in particular, our increased focus on US health care.”
Boots has more than 2,200 stores worldwide.
“We can confirm that Walgreens Boots Alliance, in line with its recently announced priorities and strategic direction that include a greater focus on US health care, has announced a strategic review, primarily focused on our successful Boots business, including No7 Beauty Company," said a company spokesperson in a statement. "This strategic review is at an exploratory stage and further announcements will be made in due course, after the right decision has been reached for Boots’ future and for all stakeholders.”
No7 is a top-selling mass color cosmetics collection.
“We have initiated a strategic review of the Boots business,” Brewer said. “This review is very much in line with our renewed priorities and strategic direction, in particular, our increased focus on US health care.”
Boots has more than 2,200 stores worldwide.
“We can confirm that Walgreens Boots Alliance, in line with its recently announced priorities and strategic direction that include a greater focus on US health care, has announced a strategic review, primarily focused on our successful Boots business, including No7 Beauty Company," said a company spokesperson in a statement. "This strategic review is at an exploratory stage and further announcements will be made in due course, after the right decision has been reached for Boots’ future and for all stakeholders.”
No7 is a top-selling mass color cosmetics collection.